In a genetically engineered KRASG12D TP53-/- ARID1A -/- mouse model, ARID1A deficiency promoted tumorigenesis of lung adenocarcinoma compared to mice that were wild-type or heterozygous for ARID1A deletion [117]. This evidence concerns the gene ARID1A and lung adenocarcinoma.